Literature DB >> 20054281

Fecal calprotectin concentration in celiac disease.

Vildan Ertekin1, Mukadder Ayşe Selimoğlu, Ahmet Turgut, Nuri Bakan.   

Abstract

GOALS: We aimed to determine fecal calprotectin (FC) concentration and its relation with histopathologic findings of children with celiac disease (CD) and to observe the probable alterations under gluten-free diet (GFD).
BACKGROUND: As FC is regarded as a marker of inflammation in the gastrointestinal tract, we hypothesized that it might be increased in untreated CD. STUDY: The study included 29 newly diagnosed patients with CD (mean age: 6.6+/-0.6 y) and sex and age-matched 10 healthy children. All of the children with CD admitted to the hospital were classical form who has chronic diarrhea and failure to thrive. The degree of mucosal damage was graded according to the modified Marsh criteria. FC concentration was determined by enzyme-linked immunosorbent assay method on admission and after 1 year of GFD.
RESULTS: Mean FC concentration of children with CD on admission and of healthy children were 13.40+/-8.5 and 4.3+/-3.3 mg/L, respectively (P=0.004). FC concentration under GFD was 4.6+/-2.7 mg/L and there was a significant statistical difference between untreated patients and those under GFD for 1 year (P=0.001). There was no statistical difference between FC concentration of those under GFD and healthy children (P=0.8). Mean FC concentrations of children with total-villous atrophy and partial-villous atrophy were significantly different (13.8+/-9.3 mg/L vs. 3.7+/-1.8 mg/L, P=0.005).
CONCLUSIONS: It was found that FC concentration is increased in childhood CD, related to the severity of histopathologic findings and responsive to GFD. The pathogenetic mechanism by which FC is increased in CD should be investigated in further studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054281     DOI: 10.1097/MCG.0b013e3181cadbc0

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  17 in total

1.  Fecal calprotectin in coeliac disease.

Authors:  Pietro Capone; Antonio Rispo; Nicola Imperatore; Nicola Caporaso; Raffaella Tortora
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

2.  Markers of systemic and gut-specific inflammation in celiac disease.

Authors:  Chiara Saroli Palumbo; Jonathan Wyse
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

Review 3.  Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.

Authors:  Bashaar Alibrahim; Mohammed I Aljasser; Baljinder Salh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

Review 4.  Practical guidance on the use of faecal calprotectin.

Authors:  Matthew J Brookes; Simon Whitehead; Daniel R Gaya; Antony Barney Hawthorne
Journal:  Frontline Gastroenterol       Date:  2017-02-22

5.  A Caucasian American patient with celiac disease diagnosed in Japan and successfully treated with a gluten-free diet.

Authors:  Haruka Wada; Mari Hayashida; Taro Sato; Shintaro Minowa; Osamu Ikezaki; Tatsuya Mitsui; Miki Miura; Yoshihiko Ohmori; Daisuke Saito; Akihito Sakuraba; Hideo Kamiichi; Kengo Tokunaga; Makoto Mochizuki; Junji Shibahara; Hideaki Mori; Tadakazu Hisamatsu
Journal:  Clin J Gastroenterol       Date:  2017-11-01

6.  The Activity of Antimicrobial Peptides in Pediatric Celiac Disease.

Authors:  Altinoy T Kamilova; Gulnoza K Azizova; Zulkhumar E Umarnazarova; Dilrabo A Abdullaeva; Svetlana I Geller
Journal:  Front Pediatr       Date:  2022-06-06       Impact factor: 3.569

Review 7.  Calprotectin: Clinical Applications in Pediatrics.

Authors:  Oscar R Herrera; Michael L Christensen; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jul-Aug

Review 8.  The role of calprotectin in pediatric disease.

Authors:  George Vaos; Ioannis D Kostakis; Nick Zavras; Athanasios Chatzemichael
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

9.  Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.

Authors:  Isabel Comino; Ana Real; Santiago Vivas; Miguel Ángel Síglez; Alberto Caminero; Esther Nistal; Javier Casqueiro; Alfonso Rodríguez-Herrera; Angel Cebolla; Carolina Sousa
Journal:  Am J Clin Nutr       Date:  2012-01-18       Impact factor: 7.045

10.  Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age.

Authors:  Marta Velasco Rodríguez-Belvís; Javier Francisco Viada Bris; Carmen Plata Fernández; Alberto García-Salido; Julia Asensio Antón; Gloria Domínguez Ortega; Rosa Ana Muñoz Codoceo
Journal:  Paediatr Child Health       Date:  2019-06-17       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.